Timothy M. Clay
- Immunology top 0.5%
- Immunotherapy and Immune Responses 54
- T-cell and B-cell Immunology 28
- Immune Cell Function and Interaction 18
- Oncology top 1%
- CAR-T cell therapy research 22
- Cancer Immunotherapy and Biomarkers 12
- Cancer Research top 2%
- Molecular Biology top 2%
- vaccines and immunoinformatics approaches 18
- Genetics top 2%
- Virus-based gene therapy research 15
-
- Monoclonal and Polyclonal Antibodies Research 15
- Co-authors
- H. Kim LyerlyMichael A. MorseAmy HobeikaTakuya OsadaMichael I. NishimuraPaul J. MoscaAlain DelcayreJean‐Bernard Le Pecq
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Expert Opinion on Biological Therapy (8 papers)International Journal of Immunogenetics (6 papers)Journal of Immunotherapy (5 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Timothy M. Clay
96 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Immunology 3.2k
- Oncology 2.2k
- Cancer Research 747
- Molecular Biology 2.6k
- Genetics 796
Countries citing papers authored by Timothy M. Clay
This map shows the geographic impact of Timothy M. Clay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy M. Clay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy M. Clay more than expected).
Fields of papers citing papers by Timothy M. Clay
This network shows the impact of papers produced by Timothy M. Clay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy M. Clay. The network helps show where Timothy M. Clay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Timothy M. Clay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 15 | |
| 2 | 2012 | 78 | |
| 3 | 2011 | 221 | |
| 4 | 2011 | 111 | |
| 5 | 2011 | 23 | |
| 6 | 2010 | 32 | |
| 7 | 2010 | 21 | |
| 8 | 2009 | 19 | |
| 9 | 2009 | 61 | |
| 10 | 2009 | 47 | |
| 11 | 2008 | 55 | |
| 12 | 2007 | 168 | |
| 13 | 2007 | 44 | |
| 14 | 2007 | 59 | |
| 15 | 2006 | 83 | |
| 16 | 2002 | 75 | |
| 17 | 2002 | 8 | |
| 18 | 1999 | 17 | |
| 19 | 1995 | 10 | |
| 20 | 1994 | 1 |
About Timothy M. Clay
Timothy M. Clay is a scholar working on Immunology, Oncology and Hematology, having authored 97 papers that have together received 5.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (54 papers), T-cell and B-cell Immunology (28 papers), CAR-T cell therapy research (22 papers), vaccines and immunoinformatics approaches (18 papers), Immune Cell Function and Interaction (18 papers), Virus-based gene therapy research (15 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Cancer Immunotherapy and Biomarkers (12 papers). The work is most often cited by research in Immunology (3.2k citations), Oncology (2.2k citations) and Cancer Research (747 citations). Timothy M. Clay has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include H. Kim Lyerly, Michael A. Morse, Amy Hobeika, Takuya Osada, Michael I. Nishimura, Paul J. Mosca, Alain Delcayre, Jean‐Bernard Le Pecq, Xiao Yang and Donna Niedzwiecki. Their work appears in journals such as Expert Opinion on Biological Therapy, International Journal of Immunogenetics, Journal of Immunotherapy, Clinical Cancer Research and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.